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Background
Over 69% of all Americans are classified as either over-
weight or obese. This epidemic has fueled the growth of
over the counter weight loss products into one of the
largest categories of nutritional supplements. However,
few of these products have undergone controlled clinical
trials to substantiate the respective advertising claims.
Furthermore, few weight loss products have been prop-
erly examined with a placebo/controlled design in
persons that are overweight or obese. The purpose of
the present investigation was to examine the effects of
the commercial weight loss/energy product, Fastin®-RR
(High-Tech Pharmaceuticals, Inc., Norcross, GA) in
overweight and obese men and women participating in
a weight loss program.
Methods
This study was carried out with seventy two men (n=36)
and women (n=36) that voluntarily participated. Inclu-
sion criteria included classification as either overweight
or obese based on testing with BodPod. All research
participants participated in the same eight week weight
loss program including general recommendations for
exercise and dietary modifications. Subjects were ran-
domly assigned to receive one of three supplement con-
ditions for the study period including FastinR-RR (FAS),
300 mg caffeine anhydrous (CAF), and cellulose placebo
condition (PL) and were instructed to take one serving
in the morning and one serving at midday. Study out-
comes were determined at baseline and after 4wks and
8wks of study. Body weight and composition were deter-
mined using BodPod. Resting hemodynamic activity
(HR, BP) was examined using an automated system
(Dynamap 1846SX; Critikon Company LLC, Tampa,
Fla). The profile of mood states (POMS-SF) was used to
determine psychological measures. Only the 59 partici-
pants that completed all testing sessions were included
in the statistical analyses (FAS, n=20; CAF, n=19;
PL=20). Primary analyses of outcome variables were per-
formed using changes scores from baseline to 8wks. Sta-
tistical analyses were conducted using one-way ANOVA
with the accepted level of significance set at p<0.05.
Consent to publish the results was obtained from all
participants.
Results
Analyses indicated that total weight loss over the 8wk
period was significantly greater with FAS (-8.0±6.5 lbs)
compared with PL (-2.6±4.8 lbs) and compared with
CAF (-3.0±5.5 lbs) (p’s < 0.05).
The FAS group also displayed statistically greater
reduction in body fat (-6.3±7.3 lbs) compared with PL
(-1.3±6.7 lbs) p<0.05). There were no statistically signifi-
cant changes in resting HR or BPs in any of the threeCorrespondence: dr_jacobs@msn.com
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study groups (FAS, CAF, PL) over the 8wk study period.
Analyses showed a significant main effect of time (base-
line to 8wks) in values of Total Mood Disorder indicat-
ing an overall reduction across the three study groups.
There were no other significant changes detected in
POMS measures over the 8wk study period in any of
the three study groups.
Conclusion
These findings indicate that total body weight and body
fat weight are significantly reduced with Fastin®-RR
(p’s<0.05). The changes in body weight and body fat
with FAS were significantly greater than those observed
with either CAF or PL. These findings showed these
beneficial changes in body composition occurred with-
out negative effects on resting hemodynamics or psy-
chological mood.
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